• Consensus Rating: Buy
  • Consensus Price Target: $7.67
  • Forecasted Upside: 171.39%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$2.83
▲ +0.18 (6.81%)

This chart shows the closing price for FORA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Forian Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FORA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FORA

Analyst Price Target is $7.67
▲ +171.39% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Forian in the last 3 months. The average price target is $7.67, with a high forecast of $13.00 and a low forecast of $5.00. The average price target represents a 171.39% upside from the last price of $2.83.

This chart shows the closing price for FORA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Forian. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/18/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/16/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/15/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/4/2024Roth MkmReiterated RatingBuy ➝ Buy$5.00Low
12/20/2023Roth CapitalReiterated RatingBuyLow
12/20/2023Roth MkmInitiated CoverageBuy$5.00Low
11/10/2023Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$11.00 ➝ $13.00Low
8/11/2023Lake Street CapitalLower TargetBuy ➝ Buy$7.00 ➝ $5.00Low
11/10/2022Royal Bank of CanadaLower TargetOutperform$24.00 ➝ $17.00Low
8/11/2022Royal Bank of CanadaLower TargetOutperform$27.00 ➝ $26.00Low
4/8/2022Lake Street CapitalInitiated CoverageBuy$9.00High
11/11/2021Royal Bank of CanadaBoost TargetOutperform$34.00 ➝ $35.00High
7/9/2021Royal Bank of CanadaInitiated CoverageOutperform$31.00Medium
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/18/2023
  • 2 very positive mentions
  • 18 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
10/18/2023
  • 3 very positive mentions
  • 20 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
11/17/2023
  • 1 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
12/17/2023
  • 2 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/16/2024
  • 1 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/15/2024
  • 5 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
3/16/2024
  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/15/2024

Current Sentiment

  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Forian logo
Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.
Read More

Today's Range

Now: $2.83
Low: $2.31
High: $2.83

50 Day Range

MA: $2.98
Low: $2.61
High: $3.64

52 Week Range

Now: $2.83
Low: $1.85
High: $4.15

Volume

12,166 shs

Average Volume

27,376 shs

Market Capitalization

$87.95 million

P/E Ratio

8.56

Dividend Yield

N/A

Beta

1.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Forian?

The following equities research analysts have issued stock ratings on Forian in the last twelve months: Lake Street Capital, Roth Capital, Roth Mkm, and Royal Bank of Canada.
View the latest analyst ratings for FORA.

What is the current price target for Forian?

3 Wall Street analysts have set twelve-month price targets for Forian in the last year. Their average twelve-month price target is $7.67, suggesting a possible upside of 179.8%. Royal Bank of Canada has the highest price target set, predicting FORA will reach $13.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $5.00 for Forian in the next year.
View the latest price targets for FORA.

What is the current consensus analyst rating for Forian?

Forian currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe FORA will outperform the market and that investors should add to their positions of Forian.
View the latest ratings for FORA.

What other companies compete with Forian?

How do I contact Forian's investor relations team?

Forian's physical mailing address is 41 University Drive, Suite 400, Newtown, PA 18940, United States. The company's listed phone number is +17203285372. The official website for Forian is forian.com. Learn More about contacing Forian investor relations.